SSCI, part of AMRI Global, will expand its nuclear magnetic resonance (NMR) spectroscopy capabilities with the addition of the Bruker AVANCE NEO 600 MHz NMR Spectrometer.
The new addition will provide SSCI with enhanced productivity for delivering high quality NMR data with increased sensitivity utilizing a cryoprobe. It aims to expand the tools that SSCI’s scientists have to support rigorous method development and validation and complex structure elucidation for small and large molecule applications, including peptides, proteins (such as monoclonal antibodies and antibody-drug conjugates), modified or unmodified ribonucleic acids (RNA), and deoxyribonucleic acids (DNA).
Patrick Tishmack, Ph.D., director of analytical development at SSCI, said, “With two NMR spectrometers configured for testing of liquid and solid samples concurrently and under cGMP, coupled with our industry-leading expertise in solid-state chemistry, will result in data and corresponding expert scientific interpretation at a standard that is unmatched in the contract solid-state and analytical services industry.”
According to the company, the new 600 MHz NMR spectrometer will be operational in late 2018.